BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ren DF, Zheng FC, Zhao JH, Shen GS, Ahmad R, Zhang SS, Zhang Y, Kan J, Dong L, Wang ZY, Zhao FX, Zhao JD. Adjuvant chemotherapy with S-1 plus oxaliplatin improves survival of patients with gastric cancer after D2 gastrectomy: A multicenter propensity score-matched study. World J Clin Cases 2018; 6(10): 373-383 [PMID: 30283800 DOI: 10.12998/wjcc.v6.i10.373]
URL: https://www.wjgnet.com/2307-8960/full/v6/i10/373.htm
Number Citing Articles
1
Zhichao Jiang, Yongkun Sun, Wen Zhang, Chengxu Cui, Lin Yang, Aiping Zhou. Comparison of S‐1 plus oxaliplatin (SOX) and capecitabine plus oxaliplatin (XELOX) as adjuvant chemotherapies for stage II and III gastric cancer after D2 resection: A single‐center retrospective studyAsia-Pacific Journal of Clinical Oncology 2020; 16(3): 180 doi: 10.1111/ajco.13321
2
Yulong Tian, Xiaodong Liu, Zixuan Wang, Shougen Cao, Zimin Liu, Qinglian Ji, Zequn Li, Yuqi Sun, Xin Zhou, Daosheng Wang, Yanbing Zhou. Concordance Between Watson for Oncology and a Multidisciplinary Clinical Decision-Making Team for Gastric Cancer and the Prognostic Implications: Retrospective StudyJournal of Medical Internet Research 2020; 22(2): e14122 doi: 10.2196/14122
3
Cheng Chen, Cheng Wu Tang, San Xiong Huang, Chun Lei Shen. Efficacy and Safety of Additional S-1 Chemotherapy to S-1 Plus Oxaliplatin Regimen Chemotherapy for Stage III Gastric Carcinoma after Radical ResectionCancer Investigation 2022; 40(1): 73 doi: 10.1080/07357907.2021.1988961
4
Qingqian Zhang, Yue Qian, Ying Yin. Comparison of S-1-based vs. capecitabine-based adjuvant chemotherapy for patients with gastric cancer: a systematic review and meta-analysisEuropean Journal of Clinical Pharmacology 2021; 77(12): 1791 doi: 10.1007/s00228-021-03187-w
5
A. A. Bobryshev, M. M. Davudov, M. N. Narimanov, S. B. Polycarpova, V. Y. Kirsanov, V. N. Blindar. THE ROLE OF ADJUVANT CHEMOTHERAPY IN THE TREATMENT OF LOCALLY ADVANCED GASTRIC CANCERSiberian journal of oncology 2021; 20(1): 133 doi: 10.21294/1814-4861-2021-20-1-133-140
6
Shan Yu, Yan Wang, Xi Cheng, Minzhi Lv, Yuehong Cui, Wei Li, Yiyi Yu, Qian Li, Tianshu Liu. <p>Prognosis of Adjuvant SOX vs XELOX Chemotherapy for Gastric Cancer After D2 Gastrectomy in Chinese Patients</p>Cancer Management and Research 2020; : 10091 doi: 10.2147/CMAR.S270387